...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: This is sort off topic but not really.

  Apparently I can only send so many messages in a day?  So Bear, Narmac and I had a very good chat.  Fingers crossed all is good come tomorrow.

 

Share
New Message
Please login to post a reply